Summit Therapeutics PLC

Healthcare · Biotechnology

18.00$ +3.7% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

Summit Therapeutics PLC (SMMT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 752 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SMMT
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q1 18	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q1 20	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	52	47	40	54	64	88	88	61	57	78	69	59	51	73	71	57	44	75	102	105	95	84	89	79	140	541	206	187	180	161	141	270	384	348	297	195	262	557	491	752
Current Assets	47	42	34	48	58	63	63	44	40	61	52	43	34	60	56	45	33	64	91	88	76	72	76	65	124	535	201	180	168	150	130	260	374	339	287	183	246	535	468	721
Cash	42	35	25	37	42	38	38	22	17	35	37	25	18	48	36	29	16	49	74	75	59	53	59	47	110	284	57	33	20	57	49	22	72	84	164	177	239	167	81	419
Cash & Short-Term Investments	42	35	25	37	42	38	38	22	17	35	37	25	18	48	36	29	16	49	74	75	59	53	59	47	110	284	196	170	164	147	125	257	371	330	280	177	–	529	454	691
Receivables	3.6	4.6	7.1	9.0	11	20	7.8	6.0	5.6	7.2	2.9	17	16	18	18	11	9.3	7.5	10	8.3	9.2	13	12	12	12	5.0	3.6	3.6	0.7	0.7	0.8	0.8	0.5	0.4	–	–	–	–	–	–
Inventory	0.0	1.6	5.3	6.2	0.0	6.2	2.4	2.5	0.0	2.5	0.0	0.0	0.0	0.0	–	-14	-14	-12	8.0	5.7	8.4	7.2	4.4	0.0	1.6	302	–	6.1	5.1	2.4	0.3	–	0.7	–	–	–	–	–	–	–
Property, Plant & Equipment	0.1	0.1	0.6	0.7	0.8	1.1	1.0	0.9	0.8	0.6	1.4	1.4	1.2	1.0	–	1.3	–	2.2	3.0	2.5	3.5	3.4	3.1	5.2	5.1	–	7.2	–	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	0.8	0.8	0.9	0.9	0.9	3.4	3.4	2.4	2.3	2.4	2.3	2.2	2.3	1.5	2.2	1.8	1.8	1.5	1.5	1.5	1.5	1.5	1.5	1.5	1.5	1.5	1.5	1.5	1.5	1.5	1.5	1.5	1.5	1.5	1.5	1.5	2.0	1.5	1.5	2.0
Intangible Assets	4.2	4.3	4.4	4.5	4.5	20	20	14	14	14	13	13	13	9.9	12	9.6	8.6	8.5	8.2	8.1	7.9	7.7	7.5	7.3	7.2	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	51	51	50	49	43	80	80	18	21	23	19	18	16	10	19	15	15	17	55	19	20	22	40	37	20	438	98	93	98	99	106	116	50	37	31	52	69	69	77	122
Current Liabilities	12	14	13	14	14	35	35	12	16	17	13	12	10	10	13	11	11	15	53	16	17	19	17	12	15	32	14	9.4	93	16	19	111	45	33	27	48	65	54	63	104
Short-Term Debt	6.9	0.0	6.9	6.9	6.9	0.4	4.6	3.4	0.5	3.4	0.5	0.4	0.5	1.0	0.4	0.4	0.3	0.3	41	0.7	0.7	0.8	0.7	0.6	1.3	17	1.4	2.3	84	2.2	2.9	82	22	3.0	2.7	2.0	–	2.5	2.4	3.6
Accounts Payable	3.9	1.1	4.1	4.6	5.2	16	16	8.7	6.8	12	8.7	7.9	9.3	3.4	3.1	6.5	1.9	4.5	3.0	5.0	4.3	3.2	5.3	2.9	1.3	0.3	0.6	0.8	2.7	2.1	5.1	2.6	2.5	3.7	3.9	17	22	15	21	23
Long-Term Debt	–	–	–	–	–	–	0.0	0.0	0.0	0.0	6.2	0.0	0.0	–	–	–	–	–	–	–	–	25	25	–	495	100	100	100	100	100	100	–	–	–	–	–	–	–	–	–
Shareholders' Equity	1.3	-4.4	-10	4.6	21	8.0	8.0	43	36	56	50	41	35	-119	52	55	29	58	47	86	76	62	49	42	120	103	108	94	82	61	35	154	334	311	267	143	192	489	414	630
Retained Earnings	-84	-92	-102	-89	-92	-137	-137	-96	-103	-100	-103	-103	-118	-119	-191	-85	-160	-155	-168	-185	-202	-222	-245	-278	-325	-308	-745	-738	-786	-786	-826	-867	-880	-971	-989	-1,542	-2,075	-1,703	-1,883	-2,699
Shares Outstanding	62	62	62	62	66	77	77	83	82	82	153	32	32	36	67	67	67	75	83	92	99	97	98	100	149	275	378	698	698	701	702	708	727	738	738	743	744	766	775	778

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings